Coherus Oncology, Inc (CHRS) insider trading

Every open-market stock purchase and sale by Coherus Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: McDavid Stilwell (CFO), $49.7K, 5 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent CHRS insider trades

DateInsiderTradeValue
Jun 5, 2026Michael Lee Ryan (Insider)Bought (not open market)—
Jun 5, 2026Charles W. Newton (Insider)Bought (not open market)—
Jun 5, 2026Charles W. Newton (Insider)Bought (not open market)—
Jun 5, 2026Mats Wahlstrom (Insider)Bought (not open market)—
Jun 5, 2026Mats Wahlstrom (Insider)Bought (not open market)—
Jun 5, 2026Jill O'Donnell-Tormey (Insider)Bought (not open market)—
Jun 5, 2026Jill O'Donnell-Tormey (Insider)Bought (not open market)—
Jun 5, 2026Michael Lee Ryan (Insider)Bought (not open market)—
Jun 5, 2026Ali J. Satvat (Insider)Bought (not open market)—
Jun 5, 2026Ali J. Satvat (Insider)Bought (not open market)—
Jun 5, 2026Rita A Karachun (Insider)Bought (not open market)—
Jun 5, 2026Rita A Karachun (Insider)Bought (not open market)—
Jun 5, 2026Lee Nisley Newcomer (Insider)Bought (not open market)—
Jun 5, 2026Lee Nisley Newcomer (Insider)Bought (not open market)—
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$9.2M
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$5.6M
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$4.2M
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$4M
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$2.5M
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$2.2M
May 29, 2026Bryan J McMichael (CFO)Sold (not open market)$1.5M
May 29, 2026Dennis M Lanfear (CEO)Sold (not open market)$1.2M
May 29, 2026Dennis M Lanfear (CEO)Bought (not open market)$795K
May 29, 2026Dennis M Lanfear (CEO)Bought (not open market)$716K
May 29, 2026Dennis M Lanfear (CEO)Bought (not open market)$640K

Who's trading CHRS

Get free alerts when an insider at Coherus Oncology, Inc files a new trade →